fludarabine has been researched along with Meningitis, Cryptococcal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chevrier, S; Houot, R; Lamy, T; Marchand, T; Poullot, E; Revest, M; Tattevin, P | 1 |
| de Marie, S; Leenders, A; Sonneveld, P | 1 |
| Aitini, E; Costa, P; Forghieri, ME; Lazzarini, L; Luzzati, R; Nicolato, A; Perboni, G; Scalzini, A; Zinzani, PL | 1 |
3 other study(ies) available for fludarabine and Meningitis, Cryptococcal
| Article | Year |
|---|---|
Early cryptococcal meningitis following treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.
Topics: Aged; Amphotericin B; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cryptococcus neoformans; Cyclophosphamide; Drug Therapy, Combination; Fatal Outcome; Flucytosine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Meningitis, Cryptococcal; Rituximab; Time Factors; Vidarabine | 2013 |
Cryptococcal meningitis following fludarabine treatment for chronic lymphocytic leukemia.
Topics: Antineoplastic Agents; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Meningitis, Cryptococcal; Middle Aged; Opportunistic Infections; Vidarabine | 1995 |
Cryptococcal meningitis and intracranial tuberculoma in a patient with Waldenstrom's macroglobulinemia treated with fludarabine.
Topics: Antineoplastic Agents; Brain Diseases; Female; Humans; Immunosuppressive Agents; Meningitis, Cryptococcal; Middle Aged; Opportunistic Infections; Tuberculoma; Vidarabine; Waldenstrom Macroglobulinemia | 1998 |